Market Place
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services. 
X
Please Wait
Applying Filters...
01 EUROAPI FRANCE (1)
02 Pharmacia and Upjohn Company LLC (1)
03 Symbiotec Pharmalab Private Limited (1)
04 Farmabios S.p.A. (1)
05 Curia Spain S.A.U. (1)
06 Curia Spain SAU (1)
07 Galenova Inc (1)
08 Isomedix Operations Inc (2)
09 Isomedix Operations, Inc (1)
10 LETCO MEDICAL, LLC (1)
11 Professional Compounding Centers of America dba PCCA (1)
12 SYMBIOTICA SPECIALITY INGREDIENTS SDN.BHD (1)
13 Spectrum Laboratory Products, Inc. (1)
14 Tianjin Tianyao Pharmaceuticals Co.,Ltd. (2)
15 zhejiang xianju pharmaceutical co., Ltd. (1)
01 DEXAMETHASONE (4)
02 Dexamethasone (7)
03 Dexamethasone Base Micronized (1)
04 Dexamethasone isonicotinate (1)
05 dexamethasone (3)
06 dexamethosone (1)
01 Canada (1)
02 China (3)
03 France (1)
04 Germany (1)
05 India (1)
06 Malaysia (1)
07 U.S.A (8)
08 United Kingdom (1)
RDD 2024
Not Confirmed
Contact Supplier
27
PharmaCompass offers a list of Dexamethasone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexamethasone manufacturer or Dexamethasone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexamethasone manufacturer or Dexamethasone supplier.
PharmaCompass also assists you with knowing the Dexamethasone API Price utilized in the formulation of products. Dexamethasone API Price is not always fixed or binding as the Dexamethasone Price is obtained through a variety of data sources. The Dexamethasone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione, including repackagers and relabelers. The FDA regulates 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione supplier is an individual or a company that provides 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione active pharmaceutical ingredient (API) or 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione finished formulations upon request. The 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione suppliers may include 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione API manufacturers, exporters, distributors and traders.
click here to find a list of 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione suppliers with NDC on PharmaCompass.
We have 13 companies offering 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione
Get in contact with the supplier of your choice:
